Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Experimental drug shows survival benefit in pancreatic cancer trial

Experimental drug shows survival benefit in pancreatic cancer trial

Study reveals why immunotherapy fails in pancreatic cancer

Study reveals why immunotherapy fails in pancreatic cancer

Alligator Bioscience provides an update on mitazalimab

Alligator Bioscience provides an update on mitazalimab

Metabolic pathways drive progression from pancreatic lesions to cancer

Metabolic pathways drive progression from pancreatic lesions to cancer

Tumor microenvironment drives resistance to ferroptosis in pancreatic cancer

Tumor microenvironment drives resistance to ferroptosis in pancreatic cancer

NCCN grants funding to five oncology leaders of the future

NCCN grants funding to five oncology leaders of the future

Popular vitamin B3 supplements could weaken cancer therapy effectiveness

Popular vitamin B3 supplements could weaken cancer therapy effectiveness

Lipid nanoparticles help CAR T cells melt pancreatic cancer barriers

Lipid nanoparticles help CAR T cells melt pancreatic cancer barriers

Gut-derived metabolites regulate immune cells in complex ways

Gut-derived metabolites regulate immune cells in complex ways

Industry and academic leaders gather to accelerate new cancer cures

Industry and academic leaders gather to accelerate new cancer cures

Molecular test shows high sensitivity in detecting bile duct cancer

Molecular test shows high sensitivity in detecting bile duct cancer

Obesity-driven organ enlargement may boost cancer risk

Obesity-driven organ enlargement may boost cancer risk

New nanomaterial enhances bioimaging and targeted cancer drug delivery

New nanomaterial enhances bioimaging and targeted cancer drug delivery

Combined CDK4/6 and EGFR inhibition improves pancreatic cancer therapy

Combined CDK4/6 and EGFR inhibition improves pancreatic cancer therapy

Fertility treatments linked to small increases in some cancers

Fertility treatments linked to small increases in some cancers

Experimental therapy eliminates pancreatic precancerous cells in mice study

Experimental therapy eliminates pancreatic precancerous cells in mice study

Romiplostim prevents chemotherapy-induced thrombocytopenia in phase 3 trial

Romiplostim prevents chemotherapy-induced thrombocytopenia in phase 3 trial

Dual-positive hybrid cells linked to shorter survival in advanced breast cancer

Dual-positive hybrid cells linked to shorter survival in advanced breast cancer

New consensus defines oligometastatic stage in pancreatic cancer

New consensus defines oligometastatic stage in pancreatic cancer

Depleting a clotting protein fibrinogen could slow down pancreatic cancer

Depleting a clotting protein fibrinogen could slow down pancreatic cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.